SCHEMBL4433726

SCHEMBL4433726

Fc1ccc(Cl)c(-c2nc3c(F)cccc3cc2CCNc2ncnc3[nH]cnc23)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 6/20 0.37
LMNA P02545 5/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
MAPK1 P28482 3/20 0.37
PIK3CD O00329 9/20 0.34
CLK4 Q9HAZ1 3/20 0.33
MAP4K4 O95819 2/20 0.33
AURKA O14965 2/20 0.33
AURKB Q96GD4 2/20 0.33
DAPK3 O43293 1/20 0.33
JAK2 O60674 1/20 0.33
PRKD3 O94806 1/20 0.33
PAK4 O96013 1/20 0.33
ABL1 P00519 1/20 0.33
LCK P06239 1/20 0.33
CSF1R P07333 1/20 0.33
RET P07949 1/20 0.33
PDGFRB P09619 1/20 0.33
FGFR1 P11362 1/20 0.33
PRKACA P17612 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4435660 0.94 PIK3CD (0.37) HTTLMNASMN1; SMN2MAPK1PIK3CD
SCHEMBL4434206 0.92 HTT (0.38) HTTLMNASMN1; SMN2MAPK1PIK3CD
SCHEMBL4443357 0.91 PIK3CD (0.40) HTTLMNASMN1; SMN2MAPK1PIK3CD
SCHEMBL4431745 0.88 HTT (0.38) HTTLMNASMN1; SMN2MAPK1PIK3CD
SCHEMBL4443103 0.86 LMNA (0.40) HTTLMNASMN1; SMN2MAPK1PIK3CD
SCHEMBL4433351 0.85 MAP4K4 (0.41) HTTLMNASMN1; SMN2MAPK1PIK3CD
SCHEMBL4429984 0.85 PIK3CD (0.37) HTTLMNASMN1; SMN2MAPK1PIK3CD
SCHEMBL4178542 0.85 PIK3CD (0.40) HTTLMNAPIK3CDCLK4MAP4K4
SCHEMBL16799113 0.84 LMNA (0.39) HTTLMNASMN1; SMN2MAPK1PIK3CD
SCHEMBL4435698 0.84 HTT (0.37) HTTLMNASMN1; SMN2MAPK1PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137186-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES Amgen Inc. (US) 2009-12-30 EP disclosed
WO-2008118468-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2008-10-02 WO disclosed